Galectin-3 Plasma Levels and Coronary Artery Disease: A New Possible Biomarker of Acute Coronary Syndrome
- 1 October 2011
- journal article
- Published by SAGE Publications in International Journal of Immunopathology and Pharmacology
- Vol. 24 (4) , 905-913
Abstract
Inflammation plays a key role in atherosclerosis. Galectin-3 is a macrophage- and endothelium-derived mediator actively involved in the regulation of many aspects of inflammatory cell behaviour. The aim of this study is to quantify plasma Galectin-3 in patients with coronary artery disease (CAD) and different clinical manifestation at the moment of observation in order to verify whether Galectin-3 could be a useful biomarker of atherosclerotic state. We enrolled 125 patients affected by CAD, angiographically documented (70 stable, 55 unstable). They underwent accurate examinations and anamnestic data was collected. The most important traditional risk factors, such as age, hypertension, and body mass index, were reported. Plasma Galectin-3 was quantified using an ELISA kit. Unstable patients (n = 55) had a higher plasma Galectin-3 levels in respect to the stable subjects (27.75 ng/mL (19.27–39.09) vs 6.48 ng/ml (4.88–8.83), p<0.001. A trend in correlation between plasma Galectin-3 levels and number of vessels compromised seems to be present: CAD patients with three-vessel disease had higher levels of Galectin-3 than patients with one-or two-vessel disease (17.39 ng/ml (10.75–29.82) vs 9.18 ng/ml (5.56–23.22), p= 0.058. The significantly higher plasma Galectin-3 levels in patients with unstable angina in respect to the stable angina confirm the involvement of Galectin-3 in promoting macrophage activation and monocyte attraction. Despite the distribution of CAD in patients with acute and chronic coronary disease being similar, we may hypothesize that Galectin-3 could be a useful biomarker of atherosclerotic plaque and in particular of its destabilization.Keywords
This publication has 28 references indexed in Scilit:
- Biomarkers of Inflammation and Oxidative Stress in AtherosclerosisBiomarkers in Medicine, 2010
- Inflammation in AtherosclerosisJACC, 2009
- Association of inflammatory markers with angiographic severity and extent of coronary artery diseaseAtherosclerosis, 2009
- The regulation of inflammation by galectin‐3Immunological Reviews, 2009
- N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectinAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Galectin-3 Is an Amplifier of Inflammation in Atherosclerotic Plaque Progression Through Macrophage Activation And Monocyte ChemoattractionArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Galectin-3 interacts with naïve and primed neutrophils, inducing innate immune responsesJournal of Leukocyte Biology, 2005
- Critical role of galectin-3 in phagocytosis by macrophagesJournal of Clinical Investigation, 2003
- Intracellular functions of galectinsBiochimica et Biophysica Acta (BBA) - General Subjects, 2002
- Extracellular functions of galectin-3Glycoconjugate Journal, 2002